| Home | E-Submission | Sitemap | Contact Us |  
top_img
   
REVIEW ARTICLE October 10, 2023
Essentials of Laboratory Issues in the Patients with Emicizumab Therapy
The recent development of emicizumab (Hemlibra, previously referred to as ACE910; Hoffman-La Roche) extends treatment options for hemophilia A patients, with and without anti-factor VIII (FVIII) inhibitors, and provides an alternative to FVIII replacement therapy for patients wi...
ORIGINAL ARTICLE October 10, 2023
Impact of Diabetes Mellitus on Platelet Reactivity after Percutaneous Coronary Intervention: Data from 3 Different Platelet Function Assays
Purpose: The present study sought to investigate the association between diabetes mellitus (DM) and platelet reactivity using three different platelet function tests in a Korean patient population. Methods: Blood sampling for platelet function analyses was performed one-day aft...
ORIGINAL ARTICLE October 10, 2023
Rapid Disappearance of Lupus Anticoagulant in COVID-19 Infection
Purpose: Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection affects various hematology-, hemostasis-, and thrombosis-related laboratory results, but controversies remain about its effect on lupus anticoagulant (LA). This study provides background content for ...
If anyone registers his/her email address, he or she will receive the email of notification when new paper is published in the web site of ceth.
Please Sign up.
eISSN : 2288-8217
pISSN : 2288-8209
Current Issue
Volume 8(1); Oct 2023
RSS feed
Review Article
1 Essentials of Laboratory Issues in the Patients with Emicizumab Therapy
Sang Hyuk Park
Clin Exp Thromb Hemost. 2023;8(1):1-4.   Published October 10, 2023
DOI: https://doi.org/10.14345/ceth.23001
                  
Original Articles
5 Impact of Diabetes Mellitus on Platelet Reactivity after Percutaneous Coronary Intervention: Data from 3 Different Platelet Function Assays
Zhao Yan Song, Moo Hyun Kim, Kwang Min Lee, Jin young Han
Clin Exp Thromb Hemost. 2023;8(1):5-12.   Published October 10, 2023
DOI: https://doi.org/10.14345/ceth.21004
                  
13 Rapid Disappearance of Lupus Anticoagulant in COVID-19 Infection
Hyunji Kim, Miyoung Kim, Young-uk Cho, Seongsoo Jang
Clin Exp Thromb Hemost. 2023;8(1):13-16.   Published October 10, 2023
DOI: https://doi.org/10.14345/ceth.22004
                  
Volume8 No. 1
Author's Index
Author's Index
Manuscript Submission
To submit a manuscript, please visit the Clin Exp Thromb Hemost e-submission management system at http://submit.e-ceth.org, read the Instructions for Authors, and log into the Clin Exp Thromb Hemost e-submission system. For assistance with manuscript submission, please contact: ksth@thrombo.or.kr.
Free archive
Anyone may access any past or current articles without logging in.
Editorial Office
Editor-in-Chief: Jae Woo Song, MD
Department of laboratory medicine, Severance Hospital,
50-1, Yonsei-Ro, Seodaemun-gu, Seoul 03722, Republic of Korea.
E-mail: LABDX@yuhs.ac

About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Korean Society on Thrombosis and Hemostasis
2714, D-dong, Yongsan Park Xi,
205, Hangang-daero, Yongsan-gu, Seoul 04322, Republic of Korea.
Tel: +82-2-790-2426, Fax: +82-2-790-2429
E-mail: ksth@thrombo.or.kr, http://www.thrombo.or.kr
Copyright© Korean Society on Thrombosis and Hemostasis.              Developed in M2PI